Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40

Targeted and immune-based therapies are thought to eradicate cancer cells by different mechanisms, and these approaches could possibly complement each other when used in combination. In this study, we report that the in vivo antitumor effects of the c-KIT inhibitor, dasatinib, on the c-KIT mutant P8...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang, Yan, Liu, Chengwen, Peng, Weiyi, Lizée, Gregory, Overwijk, Willem W., Liu, Yang, Woodman, Scott E., Hwu, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Immunobiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3512233/
https://ncbi.nlm.nih.gov/pubmed/22936666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-407163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados